RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
The Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leuke...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|
| _version_ | 1826290824065843200 |
|---|---|
| author | Wilkinson, A Ballabio, E Geng, H North, P Tapia, M Kerry, J Biswas, D Roeder, R Allis, C Melnick, A de Bruijn, M Milne, T |
| author_facet | Wilkinson, A Ballabio, E Geng, H North, P Tapia, M Kerry, J Biswas, D Roeder, R Allis, C Melnick, A de Bruijn, M Milne, T |
| author_sort | Wilkinson, A |
| collection | OXFORD |
| description | The Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leukemic phenotypes even when expressed in the same cell type, but how this distinction is delineated on a molecular level is poorly understood. Here, we highlight a unique molecular mechanism whereby the RUNX1 gene is directly activated by MLL-AF4 and the RUNX1 protein interacts with the product of the reciprocal AF4-MLL translocation. These results support a mechanism of transformation whereby two oncogenic fusion proteins cooperate by activating a target gene and then modulating the function of its downstream product. |
| first_indexed | 2024-03-07T02:50:06Z |
| format | Journal article |
| id | oxford-uuid:ad651e9c-c9f0-4780-abf9-00a909ff8b16 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:50:06Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:ad651e9c-c9f0-4780-abf9-00a909ff8b162022-03-27T03:35:20ZRUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ad651e9c-c9f0-4780-abf9-00a909ff8b16EnglishSymplectic Elements at Oxford2013Wilkinson, ABallabio, EGeng, HNorth, PTapia, MKerry, JBiswas, DRoeder, RAllis, CMelnick, Ade Bruijn, MMilne, TThe Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leukemic phenotypes even when expressed in the same cell type, but how this distinction is delineated on a molecular level is poorly understood. Here, we highlight a unique molecular mechanism whereby the RUNX1 gene is directly activated by MLL-AF4 and the RUNX1 protein interacts with the product of the reciprocal AF4-MLL translocation. These results support a mechanism of transformation whereby two oncogenic fusion proteins cooperate by activating a target gene and then modulating the function of its downstream product. |
| spellingShingle | Wilkinson, A Ballabio, E Geng, H North, P Tapia, M Kerry, J Biswas, D Roeder, R Allis, C Melnick, A de Bruijn, M Milne, T RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title | RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title_full | RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title_fullStr | RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title_full_unstemmed | RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title_short | RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. |
| title_sort | runx1 is a key target in t 4 11 leukemias that contributes to gene activation through an af4 mll complex interaction |
| work_keys_str_mv | AT wilkinsona runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT ballabioe runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT gengh runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT northp runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT tapiam runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT kerryj runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT biswasd runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT roederr runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT allisc runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT melnicka runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT debruijnm runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction AT milnet runx1isakeytargetint411leukemiasthatcontributestogeneactivationthroughanaf4mllcomplexinteraction |